Case number 1:18-cv-00114
H. Lundbeck A/S et al v. MSN Laboratories Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 19, 2021 | 28 | Consent Judgment (3) Docket Text: CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 1/19/21. (ntl) |
| Jul 19, 2019 | 27 | Answer to Complaint (30) Docket Text: [REDACTED PUBLIC VERSION] ANSWER to [1] Complaint, (Frist Amended Complaint), Affirmative Defenses, COUNTERCLAIM against H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. by MSN Laboratories Private Limited, MSN Pharmachem Private Limited, MSN Pharmaceuticals, Inc. (Grivner, Geoffrey) Modified on 7/19/2019 (ntl). |
| May 28, 2019 | 26 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Nadiia Sagarovska Loizides on behalf of All Defendants (Loizides, Nadiia) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb) |
| Jan 10, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak) |
| Aug 8, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Philip L. Hirschhorn for MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., and MSN Pharmachem Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00088-LPS, 1:18-cv-00114-LPS, 1:18-cv-00853-LPS(ceg) Modified on 6/6/2019 (ddp). |
| Aug 2, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Erin M. Dunston for MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., and MSN Pharmachem Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00114-LPS, 1:18-cv-00088-LPS, 1:18-cv-00853-LPS(ceg) |
| Jul 31, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Matthew L. Fedowitz for MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00114-LPS, 1:18-cv-00088-LPS, 1:18-cv-00853-LPS(crb) |
| Jul 31, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Mythili Markowski for MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-00114-LPS, 1:18-cv-00088-LPS, 1:18-cv-00853-LPS(crb) |
| Jul 9, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl) |
| Jul 3, 2018 | 25 | Letter to The Honorable Leonard P. Stark (1) |
| Jul 3, 2018 | 25 | Proposed Order (22) Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack) |
| Jun 19, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 12, 2018 | 24 | Cover Letter (1) |
| Jun 12, 2018 | 24 | Proposed Order (23) Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 1:18-cv-00177-LPS, 21 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00114-LPS, 17 in 1:18-cv-00147-LPS, 41 in 1:18-cv-00175-LPS, 15 in 1:18-cv-00092-LPS, 12 in 1:18-cv-00672-LPS, 13 in 1:18-cv-00671-LPS, 28 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00113-LPS, 11 in 1:18-cv-00753-LPS, 9 in 1:18-cv-00777-LPS, 23 in 1:18-cv-00148-LPS, 20 in 1:18-cv-00150-LPS, 20 in 1:18-cv-00176-LPS, 19 in 1:18-cv-00091-LPS, 17 in 1:18-cv-00090-LPS, 16 in 1:18-cv-00149-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/7/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 6, 2018 | 23 | Stipulation to EXTEND Time (14) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| May 23, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Court will hold a Case Management Conference in courtroom 6B on June 19, 2018 at 9:00 a.m. In preparation for the CMC, counsel shall meet and confer and address the items listed in the "Checklist," and submit a proposed scheduling order no later than June 6, 2018. ORDERED by Judge Leonard P. Stark on 5/23/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Apr 30, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] MOTION for Pro Hac Vice Appearance of Attorney Mythili Markowski filed by MSN Pharmachem Private Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., [18] MOTION for Pro Hac Vice Appearance of Attorney Matthew L. Fedowitz filed by MSN Pharmachem Private Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., [17] MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn filed by MSN Pharmachem Private Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., [20] MOTION for Pro Hac Vice Appearance of Attorney Erin M. Dunston filed by MSN Pharmachem Private Limited, MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/30/18. (ntl) |
| Apr 27, 2018 | 18 | Text of Proposed Order for Matthew L. Fedowitz (1) |
| Apr 27, 2018 | 17 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Philip L. Hirschhorn - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited. (Attachments: # (1) Affidavit Certification of Counsel for Philip Hirschhorn, # (2) Text of Proposed Order for Philip Hirschhorn)(Grivner, Geoffrey) |
| Apr 27, 2018 | 17 | Text of Proposed Order for Philip Hirschhorn (1) |
| Apr 27, 2018 | 18 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew L. Fedowitz - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited. (Attachments: # (1) Affidavit Certification of Counsel for Matthew L. Fedowitz, # (2) Text of Proposed Order for Matthew L. Fedowitz)(Grivner, Geoffrey) |
| Apr 27, 2018 | 18 | Affidavit Certification of Counsel for Matthew L. Fedowitz (2) |
| Apr 27, 2018 | 19 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mythili Markowski - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited. (Attachments: # (1) Affidavit Certification of Counsel for Mythili Markowski, # (2) Text of Proposed Order Mythili Markowski)(Grivner, Geoffrey) |
| Apr 27, 2018 | 19 | Affidavit Certification of Counsel for Mythili Markowski (2) |
| Apr 27, 2018 | 19 | Text of Proposed Order Mythili Markowski (1) |
| Apr 27, 2018 | 20 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Erin M. Dunston - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited. (Attachments: # (1) Affidavit Certification of Counsel for Erin M. Dunston, # (2) Text of Proposed Order for Erin M. Dunston)(Grivner, Geoffrey) |
| Apr 27, 2018 | 20 | Affidavit Certification of Counsel for Erin M. Dunston (2) |
| Apr 27, 2018 | 20 | Text of Proposed Order for Erin M. Dunston (1) |
| Apr 27, 2018 | 21 | Answer to Counterclaim (19) Docket Text: ANSWER to [15] Answer to Complaint,, Counterclaim, by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack) |
| Apr 27, 2018 | 17 | Affidavit Certification of Counsel for Philip Hirschhorn (2) |
| Apr 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:18-cv-00147-LPS, 19 in 1:18-cv-00148-LPS, 12 in 1:18-cv-00177-LPS, 14 in 1:18-cv-00149-LPS, 14 in 1:18-cv-00090-LPS, 17 in 1:18-cv-00150-LPS, 18 in 1:18-cv-00176-LPS, 11 in 1:18-cv-00092-LPS, 16 in 1:18-cv-00114-LPS, 19 in 1:18-cv-00113-LPS, 18 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00175-LPS, 16 in 1:18-cv-00091-LPS) MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 4/26/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Apr 25, 2018 | 16 | Motion for Leave to Appear Pro Hac Vice (19) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Dellinger, Megan) |
| Apr 6, 2018 | 15 | Exhibit Defendants MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., (2) |
| Apr 6, 2018 | 15 | Answer to Complaint (32) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by MSN Laboratories Private Limited, MSN Pharmachem Private Limited, MSN Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit Defendants MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., and MSN Pharmachem Private Limited Corporate Disclosure Statement Under Fed. R. Civ. P. 7.1)(Grivner, Geoffrey) |
| Feb 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] Stipulation Regarding Caption Change re MSN Laboratories Private Limited. Signed by Judge Leonard P. Stark on 2/13/18. (ntl) |
| Feb 12, 2018 | 14 | Stipulation (2) Docket Text: STIPULATION Regarding Caption Change by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Noreika, Maryellen) |
| Feb 9, 2018 | 13 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For MSN Pharmaceuticals, Inc. waiver sent on 2/5/2018, answer due 4/6/2018. (Noreika, Maryellen) |
| Feb 9, 2018 | 12 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to MSN Pharmaceuticals, Inc. on 2/5/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/7/2018. (Noreika, Maryellen) |
| Feb 9, 2018 | 11 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For MSN Pharmachem Private Limited waiver sent on 2/5/2018, answer due 4/6/2018. (Noreika, Maryellen) |
| Feb 9, 2018 | 10 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to MSN Pharmachem Private Limited on 2/5/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/7/2018. (Noreika, Maryellen) |
| Feb 9, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For MSN Private Laboratories Limited waiver sent on 2/5/2018, answer due 4/6/2018. (Noreika, Maryellen) |
| Feb 9, 2018 | 8 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to MSN Private Laboratories Limited on 2/5/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/7/2018. (Noreika, Maryellen) |
| Jan 30, 2018 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Geoffrey Graham Grivner on behalf of MSN Pharmaceuticals, Inc., MSN Pharmachem Private Limited, MSN Private Laboratories Limited (Grivner, Geoffrey) |
| Jan 24, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00113-LPS, 1:18-cv-00114-LPS (rjb) |
| Jan 19, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Private Laboratories Limited on 1/19/2018; MSN Pharmaceuticals, Inc. on 1/19/2018; MSN Pharmachem Private Limited on 1/19/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
| Jan 19, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceutical International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharma A/S, Corporate Parent Takeda Europe Holdings B.V., Corporate Parent Takeda Europe Holdings B.V. for Takeda Pharmaceuticals International AG; Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharma A/S for Takeda Pharmaceutical Company Ltd. filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. (crb) |
| Jan 19, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (crb) |
| Jan 19, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2; 8,969,355 B2; 9,227,946 B2. (crb) |
| Jan 19, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/8/2017. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 3/30/2021. (crb) |
| Jan 19, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Jan 19, 2018 | 1 | Civil Cover Sheet (2) |
| Jan 19, 2018 | 1 | Exhibit A - C (144) |
| Jan 19, 2018 | 1 | Complaint* (1) |
